Omnia Family Wealth LLC Buys 189 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Omnia Family Wealth LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 45.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 603 shares of the healthcare conglomerate’s stock after acquiring an additional 189 shares during the quarter. Omnia Family Wealth LLC’s holdings in UnitedHealth Group were worth $317,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. International Assets Investment Management LLC boosted its position in UnitedHealth Group by 53,573.1% in the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after purchasing an additional 2,348,107 shares during the last quarter. Jennison Associates LLC boosted its position in UnitedHealth Group by 49.3% in the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after purchasing an additional 1,195,352 shares during the last quarter. Mawer Investment Management Ltd. boosted its position in UnitedHealth Group by 75.0% in the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock worth $1,014,002,000 after purchasing an additional 862,024 shares during the last quarter. California Public Employees Retirement System lifted its position in shares of UnitedHealth Group by 35.9% during the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after buying an additional 815,822 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its position in shares of UnitedHealth Group by 20.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after buying an additional 623,631 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

Shares of UNH traded up $1.49 during mid-day trading on Friday, reaching $495.35. The company had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $455.76 billion, a P/E ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. The stock has a 50 day moving average of $485.84 and a two-hundred day moving average of $514.14.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the business earned $6.26 earnings per share. The company’s revenue was up 8.6% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Ratings Changes

Several analysts recently issued reports on UNH shares. Oppenheimer reissued an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Barclays boosted their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a report on Thursday, April 4th. Finally, Royal Bank of Canada dropped their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.